Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.88 USD
Change Today -0.07 / -2.37%
Volume 3.5M
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew L. Pecora M.D., F.A.C.P.

Director, Neostem, Inc.
AgeTotal Calculated CompensationThis person is connected to 59 board members in 5 different organizations across 8 different industries.

See Board Relationships
57--
As of Fiscal Year 2014

Background*

Dr. Andrew L. Pecora, M.D., F.A.C.P., founded Amorcyte, LLC in 2005 and serves as its Chief Scientific Officer. Dr. Pecora is the Founder and Executive Chairman of COTA, Inc. and Cota. He serves as the Chairman of Cancer Center Department at Hackensack University Medical Center. He serves as the Chief Medical Officer of Progenitor Cell Therapy, LLC , a wholly-owned Subsidiary of Neostem, Inc. since January 19, 2011 and also served as its Chief Visionary Officer since ...

Read Full Background

Corporate Headquarters*

420 Lexington Avenue
New York, New York 10170

United States

Phone: 212-584-4180
Fax: 646-514-7787

Board Members Memberships*

Chief Medical Officer
Founder and Chief Scientific Officer
Chairman
Founder and Executive Chairman
Founder and Executive Chairman
2004-2014
Former Director
2007-Present
Chairman
2011-Present
Director

Education*

MD
University of Medicine and Dentistry of New Jersey
BS
Seton Hall University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NBS:US $2.88 USD -0.07

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOSTEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.